New Molecular Mechanisms for Cardiovascular Disease: Cardiac Hypertrophy and Cell-Volume Regulation
Abstract.: Cardiac hypertrophy is an increase in the muscle volume of the ventricle due to the enlargement of cardiac cells. Physiological cardiac hypertrophy is the normal response to healthy exercise, and pathological hypertrophy is the response to increased stress such as hypertension. Intracellu...
Main Authors: | Shintaro Yamamoto, Satomi Kita, Takuya Iyoda, Toshiki Yamada, Takahiro Iwamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319306735 |
Similar Items
-
Topics on the Na+/Ca2+ Exchanger: Role of Vascular NCX1 in Salt-Dependent Hypertension
by: Takahiro Iwamoto, et al.
Published: (2006-01-01) -
The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy
by: Wei Yu, et al.
Published: (2020-12-01) -
Translating Translation to Mechanisms of Cardiac Hypertrophy
by: Michael J. Zeitz, et al.
Published: (2020-03-01) -
Study of Thiazolidinedione-Induced Plasma Volume Expansion and Cardiac Hypertrophy
by: Cherng-ShyangChang, et al.
Published: (2014) -
TRANSCRIPTIONAL REGULATION OF CARDIAC HYPERTROPHY AND HEART FAILURE
by: XU, JIAN
Published: (2006)